News Release

TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference

Jul, 28 2021 at 4:05 PM EDT

ANDOVER, Mass., July 28, 2021 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that members of the management team will participate in a virtual fireside chat at the upcoming Canaccord Genuity 41st Annual Growth Conference. The fireside chat will take place on Wednesday, August 11, 2021 at 4:30 p.m. Eastern Time.

Event: Canaccord Genuity 41st Annual Growth Conference
Date: Wednesday, August 11, 2021
Time: 4:30 p.m. ET

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.


Cision View original content to download multimedia:

SOURCE TransMedics Group, Inc.

Investor Contact: Brian Johnston, 631-807-1986,